Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
(1 site) United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Key details Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
United States Department of Defense, Prostate Cancer Foundation
Enrollment target
~58 participants
Primary completion
March 2031
Age range
18 Years and older
Last updated February 2026